Review
Clinical Neurology
Spyros Papapetropoulos, Angela Pontius, Elizabeth Finger, Virginija Karrenbauer, David S. Lynch, Matthew Brennan, Samantha Zappia, Wolfgang Koehler, Ludger Schoels, Stefanie N. Hayer, Takuya Konno, Takeshi Ikeuchi, Troy Lund, Jennifer Orthmann-Murphy, Florian Eichler, Zbigniew K. Wszolek
Summary: This paper comprehensively reviews the various aspects of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), including genetics, neuropathology, imaging findings, prevalence, clinical course, diagnosis/clinical evaluation, potential biomarkers, and current and proposed treatments. It also discusses potential efficacy endpoints for future clinical trials and the burden of the disease on patients and caregivers. The information in this paper lays a foundation for the development of therapeutic agents for ALSP and the design of future clinical trials with meaningful endpoints.
FRONTIERS IN NEUROLOGY
(2022)
Article
Medicine, General & Internal
Hee Jung Kwon, Duk L. Na, Hee Jin Kim, Yeon-Lim Suh
Summary: Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia is a rare neurological disorder characterized by dysarthria and cognitive decline. It is associated with T2 hyperintensities in subcortical and periventricular white matter. Genetic analysis identified heterozygous variants in the colony stimulating factor-1 receptor gene in the diagnosed cases. Pathological examination revealed severe white matter degeneration with loss of myelinated axons, but varying levels of axonal spheroids and pigmented macrophages. This disorder should be considered in patients with presenile dementia and diffuse white matter lesions.
Article
Clinical Neurology
Cong Ding, Li Zhao, Yu Zhan, Jiahao Li, Rujia Zhong, Qingwei Song, Chunbo Dong
Summary: Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a rare genetic disorder caused by mutations in the CSF1R gene, resulting in white matter changes and cognitive impairment.
NEUROLOGICAL SCIENCES
(2022)
Article
Clinical Neurology
Xavier Ayrignac, Clarisse Carra-Dalliere, Pekes Codjia, Kevin Mouzat, Giovanni Castelnovo, Emmanuel Ellie, Frederique Etcharry-Bouyx, Serge Belliard, Cecilia Marelli, Florence Portet, Isabelle Le Ber, Francoise Durand-Dubief, Guillaume Mathey, Bruno Stankoff, Imen Dorboz, Severine Drunat, Odile Boespflug-Tanguy, Nicolas Menjot de Champfleur, Serge Lumbroso, Fanny Mochel, Pierre Labauge
Summary: The diagnostic criteria for ALSP have limited sensitivity and modest specificity overall, suggesting the need for a comprehensive approach including magnetic resonance imaging pattern-based analysis and genetic testing like white matter gene panel or whole exome sequencing in patients suspected of genetic leukoencephalopathy.
EUROPEAN JOURNAL OF NEUROLOGY
(2022)
Review
Biochemistry & Molecular Biology
Isidro Ferrer
Summary: This article introduces several genetic disorders that cause damage to cerebral white matter. The naming of these diseases can be confusing, with different terms being used to designate the same disease. CSF1R mutations cause CSF-1R-related leukoencephalopathy (CRP), while AARS2 mutations lead to a mitochondrial disease called ALSP. PLOSL is a systemic disease caused by mutations in the genes TYROBP or TREM2.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Clinical Neurology
Pei-Chien Tsai, Jong-Ling Fuh, Chih-Chao Yang, Anna Chang, Li-Ming Lien, Pei-Ning Wang, Kuan-Lin Lai, Yu-Shuen Tsai, Yi-Chung Lee, Yi-Chu Liao
Summary: CSF1R mutations account for 3.5% of adult-onset leukoencephalopathy in Taiwan, leading to cognitive decline, psychiatric symptoms, and rapid deterioration of cognitive function in affected patients.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
(2021)
Article
Clinical Neurology
Cristina Moreno Loscertales, Paula Canasto Jimenez, Mario Bautista Lacambra, Luisa Tique Rojas, Silvia Izquierdo Alvarez, Eugenia Marta Moreno
Summary: This paper reports a case of a 67-year-old man with a history of progressive impairment of behavioral and cognitive functions. The patient presented symptoms such as apathy, inhibition, tendency to mutism, and deficits in complex planning skills. The diagnosis was confirmed as colony-stimulating factor 1 receptor-related adult-onset leukoencephalopathy based on genetic testing and brain imaging findings. This is the first documented case in Spain, highlighting the underdiagnosis of this condition and the importance of brain imaging for its diagnosis.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS
(2023)
Article
Oncology
Min Chu, Dong-Xin Wang, Yue Cui, Yu Kong, Li Liu, Ke-Xin Xie, Tian-Xinyu Xia, Jing Zhang, Ran Gao, Ai-Hong Zhou, Chao-Dong Wang, Li-Yong Wu
Summary: This study conducted whole-exome sequencing on nine Chinese patients with ALSP, identifying seven CSF1R mutations, including four known and three novel mutations. These findings expand the understanding of the mutational spectrum of ALSP and provide a basis for future research on etiologic factors and potential management strategies.
ANNALS OF TRANSLATIONAL MEDICINE
(2021)
Article
Clinical Neurology
Ka Young Lim, Seong-Ik Kim, Hyunhee Kim, Jeongwan Kang, Jin Woo Park, Jae Kyung Won, Dong-Yeop Shin, Sung-Hye Park
Summary: This report describes two cases that confirm the clinicopathological features of chemotherapy-induced toxic leukoencephalopathy, emphasizing that chemotherapy drugs other than methotrexate can also cause this disease.
Article
Multidisciplinary Sciences
Miguel A. Arreola, Neelakshi Soni, Joshua D. Crapser, Lindsay A. Hohsfield, Monica R. P. Elmore, Dina P. Matheos, Marcelo A. Wood, Vivek Swarup, Ali Mortazavi, Kim N. Green
Summary: The study showed that microglial CSF1R haploinsufficiency leads to microglial dysregulation, characterized by reduced expression of cellular markers, and synaptic and extracellular matrix deficits. Treatment with a CSF1R inhibitor prevented these abnormalities, highlighting the potential therapeutic benefit of targeting CSF1R in mitigating the pathogenesis of the disease.
Article
Clinical Neurology
Panagiotis Stoiloudis, Dimitrios Parissis, Nikoletta Smyrni, Thomai Stardeli, Theodora Afrantou, Eleni Konstantinopoulou, Nikolaos Grigoriadis, Panagiotis Ioannidis
Summary: HDLS is an adult onset leukodystrophy caused by mutations in the CSF1R gene. Patients may present with PPA-like symptoms, and early diagnosis is crucial for potential treatment.
NEUROLOGICAL SCIENCES
(2021)
Article
Clinical Neurology
Qin Du, Minjin Wang, Hongyu Zhou
Summary: A novel missense mutation, p.L755P, in the CSF1R gene was identified in a Chinese family with autosomal-dominant HDLS, expanding the genetic spectrum of CSF1R-associated HDLS. Three patients in the family showed typical manifestations of HDLS, while a 10-year-old gene carrier remains asymptomatic. Brain MRI revealed diffuse white matter changes in affected individuals.
NEUROLOGICAL SCIENCES
(2022)
Review
Genetics & Heredity
Long Guo, Shiro Ikegawa
Summary: Mutations in CSF1R can cause various monogenic disorders, with the new disease BANDDOS showing a more severe and diverse phenotype, including brain abnormalities and skeletal dysplasia. A dose-dependent model is proposed to explain the complex genotype-phenotype association.
JOURNAL OF HUMAN GENETICS
(2021)
Article
Clinical Neurology
Ekaterina Kazakova, Jose Alberto Tellez-Martinez, Leonardo Flores-Lagunes, Ana Luisa Sosa-Ortiz, Karol Carillo-Sanchez, Carolina Molina-Garay, Carlos Alberto Gonzalez-Dominguez, Marco Jimenez-Olivares, Francisca Fernandez-Valverde, Edwin Steven Vargas-Canas, Martha Elisa Vazquez-Memije, Ethel Awilda Garcia-Latorre, Ivan Martinez-Duncker, Carmen Alaez-Verson
Summary: This study reports the first Mexican case of AARS2 mutations causing primary ovarian failure, uterus infantilis, and early-onset dementia secondary to leukoencephalopathy. Detailed clinical, clinimetric, neuroimaging, and molecular studies were conducted. The study expands the genetic and phenotypic spectrum of AARS2-related dementia with leukoencephalopathy and ovarian failure and characterizes novel molecular variants.
FRONTIERS IN NEUROLOGY
(2023)
Article
Neurosciences
Fabrizio Biundo, Violeta Chitu, Gabriel G. L. Shlager, Eun S. Park, Maria E. Gulinello, Kusumika Saha, Harmony C. Ketchum, Christopher Fernandes, Solen Gokhan, Mark F. Mehler, E. Richard Stanley
Summary: Studies have shown that loss of microglia cells can lead to behavioral deficits, pathology, and increased Csf2 expression in CSF1R-deficient mice, but not neural deletion. Additionally, increased Csf2 expression was observed in callosal astrocytes, oligodendrocytes, and microglia, with increased cell densities in regions with activated microglia in CSF1R-deficient mice. These findings confirm the involvement of microglia in the pathogenesis of ALSP and provide insights for future therapeutic strategies.
Review
Medicine, General & Internal
Goda-Camille Mickeviciute, Monika Valiuskyte, Michael Platten, Zbigniew K. Wszolek, Oluf Andersen, Virginija Danylaite Karrenbauer, Benjamin Ineichen, Tobias Granberg
Summary: CSF1R-related leukoencephalopathy is characterized by progressive white matter lesions and brain atrophy, with main MRI findings including frontoparietal white matter lesions, callosal thinning, and foci of restricted diffusion. Long-lasting diffusion restriction and parenchymal calcifications are more specific findings that aid in differential diagnosis.
JOURNAL OF INTERNAL MEDICINE
(2022)
Editorial Material
Genetics & Heredity
Eiichiro Amano, Tomokatsu Yoshida, Ikuko Mizuta, Jun Oyama, Shingo Sakashita, Syunsuke Ueyama, Akira Machida, Takanori Yokota
Summary: This case report describes an autopsied case of adult-onset Alexander disease with a novel splice site mutation. The patient presented mild upper motor neuron symptoms despite severe spinal cord and medulla oblongata atrophy. Genetic testing revealed a mutation in the canonical splice acceptor site, leading to activation of a cryptic splice acceptor site and expanding the clinical spectrum of ALXDRD.
NEUROLOGY-GENETICS
(2021)
Letter
Clinical Neurology
Tomone Taneda, Masato Kanazawa, Yo Higuchi, Hironori Baba, Aiko Isami, Masahiro Uemura, Takuya Konno, Arata Horii, Takeshi Ikeuchi, Osamu Onodera
MOVEMENT DISORDERS CLINICAL PRACTICE
(2022)
Article
Biochemistry & Molecular Biology
Lukasz M. Milanowski, Xu Hou, Jenny M. Bredenberg, Fabienne C. Fiesel, Liam T. Cocker, Alexandra Soto-Beasley, Ronald L. Walton, Audrey J. Strongosky, Ayman H. Faroqi, Maria Barcikowska, Magdalena Boczarska-Jedynak, Jaroslaw Dulski, Lyuda Fedoryshyn, Piotr Janik, Anna Potulska-Chromik, Katherine Karpinsky, Anna Krygowska-Wajs, Tim Lynch, Diana A. Olszewska, Grzegorz Opala, Aleksander Pulyk, Irena Rektorova, Yanosh Sanotsky, Joanna Siuda, Mariusz Widlak, Jaroslaw Slawek, Monika Rudzinska-Bar, Ryan Uitti, Monika Figura, Stanislaw Szlufik, Sylwia Rzonca-Niewczas, Elzbieta Podgorska, Pamela J. McLean, Dariusz Koziorowski, Owen A. Ross, Dorota Hoffman-Zacharska, Wolfdieter Springer, Zbigniew K. Wszolek
Summary: This study identified a potential genetic cause of Parkinson's disease in two affected siblings. However, functional analysis of patient-derived fibroblasts did not reveal significant changes, suggesting that the CTSB gene may harbor variants with different penetrance that can determine disease risk.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Clinical Neurology
Jaroslaw Dulski, Catalina Cerquera-Cleves, Lukasz Milanowski, Jolanta Kwiatek-Majkusiak, Dariusz Koziorowski, Owen A. Ross, Jolanta Pentela-Nowicka, Jaroslaw Slawek, Zbigniew K. Wszolek
Summary: Patients with Perry syndrome (PS) show a marked and sustained response to L-Dopa and L-Dopa-induced dyskinesia (LID). The characteristic pattern of craniocervical dystonia may be a helpful clue to the diagnosis of PS.
PARKINSONISM & RELATED DISORDERS
(2022)
Letter
Clinical Neurology
Jaroslaw Dulski, Alexandra Estela Soto Pina, Rana Hanna Al-Shaikh, Leonard Petrucelli, Zbigniew K. Wszolek
NEUROLOGICAL SCIENCES
(2023)
Editorial Material
Clinical Neurology
Jaroslaw Dulski, Erik H. Middlebrooks, Zbigniew K. Wszolek
Summary: This article describes the screening and diagnosis process of a 24-year-old woman with a family history of early-onset dementia and leukoencephalopathy. The use of MRI provided additional diagnostic accuracy and helped guide treatment decisions.
Letter
Clinical Neurology
Shan Ali, Philip W. Tipton, Shunsuke Koga, Erik H. Middlebrooks, Keith A. Josephs, Audrey Strongosky, Dennis W. Dickson, Zbigniew K. Wszolek
PARKINSONISM & RELATED DISORDERS
(2022)
Article
Clinical Neurology
Jaroslaw Dulski, Rana Hanna Al-Shaikh, Anna Sulek, Jakub Kasprzak, Jaroslaw Slawek, Zbigniew K. Wszolek
Summary: This letter reports the first three families with SCA3 from Poland and discusses the practical implications of the disease for clinicians. It is the first time SCA3 has been reported in Eastern Europe.
PARKINSONISM & RELATED DISORDERS
(2022)
Article
Clinical Neurology
Shunsuke Koga, Shan Ali, Matthew C. Baker, Klaas J. Wierenga, Michelle Dompenciel, Dennis W. Dickson, Zbigniew K. Wszolek
Summary: Sporadic, adult-onset cerebellar ataxia is a disease with multiple etiologies. In this viewpoint article, two patients with rapidly progressive disease course and extracerebellar symptoms resembling prion disease are described. Pathological findings reveal degenerative changes in both the cerebellar cortex and thalamus. Whole genome sequencing did not identify any pathogenic variants associated with cerebellar ataxia.
PARKINSONISM & RELATED DISORDERS
(2022)
Article
Pharmacology & Pharmacy
Jaroslaw Dulski, Michael G. Heckman, Launia J. White, Kamila Zur-Wyrozumska, Troy C. Lund, Zbigniew K. Wszolek
Summary: This study aimed to identify predictors of good and bad outcomes in CSF1R-ALSP patients who underwent HSCT. The results showed that gait problems were associated with a milder phenotype and better response to HSCT, while cognitive impairment was predictive of poor prognosis and worsening cognition post-HSCT.
Review
Genetics & Heredity
Jaroslaw Dulski, Josiane Souza, Mara Lucia Santos, Zbigniew K. Wszolek
Summary: CSF1R mutations cause two different diseases, CSF1R-related leukoencephalopathy with axonal spheroids and pigmented glia (CSF1R-ALSP) and BANDDOS. While CSF1R-ALSP has been increasingly recognized and treated, there is limited literature on BANDDOS. This review analyzes BANDDOS and compares it to CSF1R-ALSP, highlighting similarities and differences. Further research is needed for the treatment of BANDDOS.
ORPHANET JOURNAL OF RARE DISEASES
(2023)
Letter
Clinical Neurology
Masahiro Uemura, Sho Kitahara, Taisuke Kato, Hiroaki Nozaki, Shoichiro Ando, Tomohiko Ishihara, Osamu Onodera
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
(2023)
Article
Clinical Neurology
Hiroaki Sekiya, Shunsuke Koga, Aya Murakami, Miki Kawazoe, Minji Kim, Nicholas B. Martin, Ryan J. Uitti, William P. Cheshire, Zbigniew K. Wszolek, Dennis W. Dickson
Summary: The study compared the diagnostic accuracy of the MDS criteria and second consensus criteria for MSA, finding that the MDS criteria had higher specificity for clinically established and probable MSA, while the second consensus criteria had higher sensitivity for probable and possible MSA.
Article
Clinical Neurology
Hiroaki Sekiya, Shunsuke Koga, Aya Murakami, Michael Deture, Owen A. Ross, Ryan J. Uitti, William P. Cheshire, Zbigniew K. Wszolek, Dennis W. Dickson
Summary: Comorbid pathologies are uncommon in multiple system atrophy (MSA), even in advanced age, indicating its uniqueness among neurodegenerative disorders. These comorbid pathologies have minimal clinical impact on MSA.
MOVEMENT DISORDERS
(2023)